EFG Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-75,748	Closed	-$1.23M	–	188
2024 Q2	$1.23M	Buy	75,748 +364	+0.5%	+$5.91K	0.21%	168
2024 Q1	$1.39M	Buy	75,384 +28,405	+60%	+$524K	0.24%	166
2023 Q4	$1.47M	Buy	46,979 +7,098	+18%	+$222K	0.28%	142
2023 Q3	$830K	Buy	+39,881	New	+$830K	0.2%	157